Sessions

 

Session 8

 

Tuesday, September 1
10:30 am – 12:30 pm

Room: Genevoix      

Functional technologies 

     
Chair: FranK Zerbib (France) – Serhat Bor (Turkey)

Panel: Valmik Bhargava (USA) – Jürgen Hochberger (Germany-France)
– Johannes Lenglinger (Austria)

 

Industry panel:

• FLIP procedure. Crospon
• SmartPill – BarrxTMRFA – GI functional diagnostic Portfolio. Medtronic – Covidien
• HRM – Impedance – pH metry. Sandhill
• Endoscopic surgery. Ethicon

___________

 

• Selected firms specializing in the field of functional technologies will be represented on stage.
• Facing them will be clinicians, each one renowned at the highest international level.

• First, a presentation by each representative of a firm, putting forth the qualities and nature of its devices, plus the future prospects its ongoing research leads to hope for in this domain.

• Then, an exchange,

• with the panel of clinicians, in the format of several, carefully drawn up questions approved beforehand by the firm,
• with the public of potential users, made up of practitioners and young investagators,
• completed after the congress by a document written by the panel, sent to the firms for approval, and made widely accessible on the IT media.

 

This interactive exchange will by no means represent a competition between firms but, on the contrary, an opportunity to put forth the advantages of their devices.

 

In addition, this session will take place in the framework of a moral charter which will guarantee that no firm participating will find itself facing competition from another Industry representative contributing to the exchange.

 

• Each Industry representative is to clearly and objectively put forth those products suited to the debate in such a way as to enlighten the public on the current and future prospects of his/her company.
• Each Industry representative will be requested to address questions following the presentation in a manner so as to exclude any negative reference to his/her competitor.